Title: Pharmacokinetic-based failure of a detergent virucidal for SARS-COV-2 nasal infections.

Authors: Esther Jr, Charles R; Kimura, Kyle S; Mikami, Yu; Edwards, Caitlin E; Das, Suman R; Freeman, Michael H; Strickland, Britton A; Brown, Hunter M; Wessinger, Bronson C; Gupta, Veerain C; Von Wahlde, Kate; Sheng, Quanhu; Huang, Li Ching; Bacon, Daniel R; Kimple, Adam J; Ceppe, Agathe S; Kato, Takafumi; Pickles, Raymond J; Randell, Scott H; Baric, Ralph S; Turner, Justin H; Boucher, Richard C

Published In Res Sq, (2021 May 14)

Abstract: The nose is the portal for SARS-CoV-2 infection, suggesting the nose as a target for topical antiviral therapies. Because detergents are virucidal, Johnson and Johnson's Baby Shampoo (J&J) was tested as a topical virucidal agent in SARS-CoV-2 infected subjects. Twice daily irrigation of J&J in hypertonic saline, hypertonic saline alone, or no intervention were compared (n = 24/group). Despite demonstrated safety and robust efficacy in in vitro virucidal assays, J&J irrigations had no impact on viral titers or symptom scores in treated subjects relative to controls. Similar findings were observed administering J&J to infected cultured human airway epithelia using protocols mimicking the clinical trial regimen. Additional studies of cultured human nasal epithelia demonstrated that lack of efficacy reflected pharmacokinetic failure, with the most virucidal J&J detergent components rapidly absorbed from nasal surfaces. This study emphasizes the need to assess the pharmacokinetic characteristics of virucidal agents on airway surfaces to guide clinical trials.

PubMed ID: 34013253

MeSH Terms: No MeSH terms associated with this publication